$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

$nhhs Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000150370720000012 Filed on May 08, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$72.89M	$72.52M
YoY Change	0.51%	-2.4%
Cost Of Revenue	$45.70M	$45.22M
YoY Change	1.07%	-2.6%
Gross Profit	$27.19M	$27.30M
YoY Change	-0.41%	-2.07%
Gross Profit Margin	37.3%	37.65%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$16.49M	$22.40M
YoY Change	-26.39%	-22.28%
% of Gross Profit	60.64%	82.04%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$16.68M	$17.40M
YoY Change	-4.12%	2.1%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$11.54M	-$18.44M
YoY Change	-37.42%	-26.97%
Income Tax	$14.00K	$6.000K
% Of Pretax Income
Net Earnings	-$12.55M	-$18.62M
YoY Change	-32.6%	-44.7%
Net Earnings / Revenue	-17.21%	-25.67%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	189.1M shares	189.1M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$36.89M	$64.60M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$21.39M	$21.39M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$265.3M	$260.3M
YoY Change	1.91%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.120B	$2.230B
YoY Change	-4.9%	-8.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$1.466B	$1.503B
YoY Change	-2.5%	-1.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.054B	-$983.0M
YoY Change	7.21%	23.9%
Common Stock	$1.705B	$1.705B
YoY Change	-0.04%	1.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$649.4M	$720.3M
YoY Change
Total Liabilities & Shareholders Equity	$2.120B	$2.230B
YoY Change	-4.9%	-8.34%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$12.55M	-$18.62M
YoY Change	-32.6%	-44.7%
Depreciation, Depletion And Amortization	$16.49M	$22.40M
YoY Change	-26.39%	-22.28%
Cash From Operating Activities	$2.429M	-$2.019M
YoY Change	-220.31%	-127.78%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$903.0K	-$547.0K
YoY Change	-265.08%
Cash From Investing Activities	-$1.265M	$2.243M
YoY Change	-156.4%	-92.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.998M	$1.978M
YoY Change	1.01%	-75.9%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$8.086M	-$13.71M
YoY Change	-41.01%	-47.17%
NET CHANGE
Cash From Operating Activities	$2.429M	-$2.019M
Cash From Investing Activities	-$1.265M	$2.243M
Cash From Financing Activities	-$8.086M	-$13.71M
Net Change In Cash	-$6.922M	-$13.48M
YoY Change	-48.67%	-240.47%
FREE CASH FLOW
Cash From Operating Activities	$2.429M	-$2.019M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	189111561	shares
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	189191862	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	189111561	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	189191862	shares
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000	USD
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001503707
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	189325195	shares
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	NorthStar Healthcare Income, Inc.
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36888000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41884000	USD
CY2020Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	13925000	USD
CY2019Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	13314000	USD
CY2020Q1	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	27887000	USD
CY2019Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	28355000	USD
CY2020Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5030000	USD
CY2020Q1	us-gaap	Other Assets OtherAssets	17082000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	14489000	USD
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	us-gaap	Assets Assets	2120298000	USD
CY2019Q4	us-gaap	Assets Assets	2141207000	USD
CY2020Q1	us-gaap	Notes Payable NotesPayable	1427440000	USD
CY2019Q4	us-gaap	Notes Payable NotesPayable	1431922000	USD
CY2019Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	1649000	USD
CY2020Q1	us-gaap	Restricted Cash RestrictedCash	15010000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	16936000	USD
CY2020Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1687267000	USD
CY2019Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1700218000	USD
CY2020Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	265309000	USD
CY2019Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	268894000	USD
CY2020Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	55281000	USD
CY2019Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	55468000	USD
CY2020Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	1649000	USD
CY2019Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5780000	USD
CY2020Q1	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	3318000	USD
CY2019Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	3292000	USD
CY2020Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	25639000	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	28135000	USD
CY2020Q1	us-gaap	Other Liabilities OtherLiabilities	4417000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	4574000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	1465844000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	1473703000	USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	1892000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	1891000	USD
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1702799000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1702260000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1053778000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1041297000	USD
CY2020Q1	us-gaap	Minority Interest MinorityInterest	5055000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	5120000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	654454000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	667504000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1514000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-470000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	649399000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	662384000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45218000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	16679000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	17396000	USD
CY2020Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	7000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2120298000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2141207000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	32847000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	31878000	USD
CY2020Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	39980000	USD
CY2019Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	40286000	USD
CY2020Q1	us-gaap	Other Operating Income OtherOperatingIncome	64000	USD
CY2019Q1	us-gaap	Other Operating Income OtherOperatingIncome	357000	USD
CY2020Q1	us-gaap	Revenues Revenues	72891000	USD
CY2019Q1	us-gaap	Revenues Revenues	72521000	USD
CY2020Q1	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	1905000	USD
CY2019Q1	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	1902000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45701000	USD
CY2019Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	38000	USD
CY2020Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	4431000	USD
CY2019Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	4994000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3029000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3054000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16489000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22399000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	86336000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	93099000	USD
CY2020Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2019Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	237000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11540000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18439000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-993000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-224000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-12547000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-18669000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-66000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-52000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12481000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18617000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-66000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	189038484	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	189005931	shares
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.03
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-12547000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-18669000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1044000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	200000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1044000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	200000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13591000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-18469000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-52000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13525000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18417000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	744374000	USD
CY2019Q1	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	2500000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	45000	USD
CY2019Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	256000	USD
CY2019Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	72000	USD
CY2019Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	1978000	USD
CY2019Q1	us-gaap	Dividends Common Stock DividendsCommonStock	5413000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	4876000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	200000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-18669000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	726119000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	667504000	USD
CY2020Q1	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	2500000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	38000	USD
CY2020Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	86000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	85000	USD
CY2020Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	1998000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1044000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-12547000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	654454000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-12547000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-18669000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-993000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-224000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16489000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22399000	USD
CY2020Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	766000	USD
CY2019Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	746000	USD
CY2020Q1	us-gaap	Straight Line Rent StraightLineRent	-11000	USD
CY2019Q1	us-gaap	Straight Line Rent StraightLineRent	189000	USD
CY2020Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	30000	USD
CY2019Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	26000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	471000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	486000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	38000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	45000	USD
CY2020Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2019Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	237000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	USD
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	325000	USD
CY2020Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2500000	USD
CY2019Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2500000	USD
CY2020Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	822000	USD
CY2019Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	438000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1690000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1688000	USD
CY2020Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-749000	USD
CY2019Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-1079000	USD
CY2020Q1	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	26000	USD
CY2019Q1	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	-133000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3217000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5820000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-10000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-465000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2429000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2019000	USD
CY2020Q1	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	2127000	USD
CY2019Q1	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	2851000	USD
CY2020Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2019Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	2400000	USD
CY2020Q1	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Financing Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsFinancingActivities	1765000	USD
CY2019Q1	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Financing Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsFinancingActivities	6947000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	903000	USD
CY2019Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-547000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1265000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2243000	USD
CY2020Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5942000	USD
CY2019Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5835000	USD
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	147000	USD
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	142000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1998000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1978000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2019Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	10813000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	0	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	4876000	USD
CY2020Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	86000	USD
CY2019Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	256000	USD
CY2020Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	85000	USD
CY2019Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	72000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8086000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13708000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6922000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13484000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58820000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94508000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51898000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81024000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	943000	USD
CY2019Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1153000	USD
CY2020Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	222000	USD
CY2019Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	193000	USD
CY2020Q1	nshi	Noncashor Part Noncash Transaction Reclassificationof Operating Real Estateto Assetsof Held For Sale NoncashorPartNoncashTransactionReclassificationofOperatingRealEstatetoAssetsofHeldForSale	0	USD
CY2019Q1	nshi	Noncashor Part Noncash Transaction Reclassificationof Operating Real Estateto Assetsof Held For Sale NoncashorPartNoncashTransactionReclassificationofOperatingRealEstatetoAssetsofHeldForSale	13513000	USD
CY2020Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Business and Organization</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), was formed to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, directly or through joint ventures, with a focus on the mid-acuity senior housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living (“ILF”) facilities and continuing care retirement communities (“CCRC”), which may have independent living, assisted living, skilled nursing and memory care available on one campus. The Company also invests in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but it also selectively makes international investments. </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company conducts its operations so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC (the “Prior Advisor”) and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), each an affiliate of the Company’s sponsor. The Prior Advisor invested </span><span style="font-family:inherit;font-size:10pt;"><span>$1,000</span></span><span style="font-family:inherit;font-size:10pt;"> in the Operating Partnership in exchange for common units and the Special Unit Holder invested </span><span style="font-family:inherit;font-size:10pt;"><span>$1,000</span></span><span style="font-family:inherit;font-size:10pt;"> in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the Company’s limited partnership interest in the Operating Partnership was </span><span style="font-family:inherit;font-size:10pt;"><span>99.99%</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s charter authorizes the issuance of up to </span><span style="font-family:inherit;font-size:10pt;"><span>400.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of common stock with a par value of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.01</span></span><span style="font-family:inherit;font-size:10pt;"> per share and up to </span><span style="font-family:inherit;font-size:10pt;"><span>50.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of preferred stock with a par value of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.01</span></span><span style="font-family:inherit;font-size:10pt;"> per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company completed its initial public offering (the “Initial Offering”) on February 2, 2015 by raising gross proceeds of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.1 billion</span></span><span style="font-family:inherit;font-size:10pt;">, including </span><span style="font-family:inherit;font-size:10pt;"><span>108.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares issued in its initial primary offering (the “Initial Primary Offering”) and </span><span style="font-family:inherit;font-size:10pt;"><span>2.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares issued pursuant to its distribution reinvestment plan (the “DRP”). In addition, the Company completed its follow-on offering (the “Follow-On Offering”) on January 19, 2016 by raising gross proceeds of </span><span style="font-family:inherit;font-size:10pt;"><span>$700.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, including </span><span style="font-family:inherit;font-size:10pt;"><span>64.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares issued in its follow-on primary offering (the “Follow-on Primary Offering”) and </span><span style="font-family:inherit;font-size:10pt;"><span>4.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares issued pursuant to the DRP. The Company refers to its Initial Primary Offering and its Follow-on Primary Offering collectively as the “Primary Offering” and its Initial Offering and Follow-On Offering collectively as the “Offering.” In December 2015, the Company registered an additional </span><span style="font-family:inherit;font-size:10pt;"><span>30.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares to be offered pursuant to the DRP. From inception through </span><span style="font-family:inherit;font-size:10pt;">May 7, 2020</span><span style="font-family:inherit;font-size:10pt;">, the Company raised total gross proceeds of </span><span style="font-family:inherit;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:inherit;font-size:10pt;">, including </span><span style="font-family:inherit;font-size:10pt;"><span>$232.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> in DRP proceeds.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company is externally managed and has </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> employees. The Company is sponsored by Colony Capital, Inc. (NYSE: CLNY) (“Colony Capital” or the “Sponsor”), which was formed as a result of the mergers of NorthStar Asset Management Group Inc.(“NSAM”), its prior sponsor, with Colony Capital, Inc. (“Colony”) and NorthStar Realty Finance Corp. (“NorthStar Realty”) in January 2017. Effective June 25, 2018, the Sponsor changed its name from Colony NorthStar, Inc. to Colony Capital, Inc. and its ticker symbol from “CLNS” to “CLNY.” Following the mergers, the Sponsor became an internally-managed equity REIT, with a diversified real estate and investment management platform. </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Colony Capital manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded REITs and registered investment companies. The Company’s advisor, CNI NSHC Advisors, LLC (the “Advisor”), is a subsidiary of Colony Capital and manages its day-to-day operations pursuant to an advisory agreement.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Impact of COVID-19</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At the time of preparation of the first quarter 2020 financial statements, the world is facing a global pandemic, the coronavirus 2019 (“COVID-19”), with efforts to address the pandemic significantly impacting economic and financial markets globally and across all facets of industries, including real estate. Specifically, the Company's healthcare real estate business and investments have begun to experience or otherwise anticipate a myriad of challenges, including, but not limited to, declines in resident occupancy </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and operating cash flows, increases in cost burden faced by operators, lease concessions sought by tenants, and a stressed market affecting real estate values in general. Most of these COVID-19 effects on the Company's business did not significantly impact results of operations during the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, but the Company anticipates more pronounced and significant effects in future periods, beginning the second quarter of 2020. While the Company itself has the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continues to permeate in an economic downturn environment. </span></div>If a general economic downturn resulting from efforts to contain COVID-19 persists over an extended period of time, this could have a prolonged negative impact on the Company's financial condition and results of operations. At this time, as the extent and duration of the increasingly broad effects of COVID-19 on the global economy remain unclear, it is difficult for the Company to assess and estimate the impact on the Company's results of operations with any meaningful precision. Accordingly, any estimates of the effects of COVID-19 as reflected and/ or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q, and such estimates may change, the effects of which could be material.
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000.0	shares
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0	shares
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1100000000	USD
CY2015Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	108600000	shares
CY2016Q1	nshi	Followon Public Offering FollowonPublicOffering	700000000.0	USD
CY2020Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	0	employee
CY2020Q1	us-gaap	Variable Interest Entity Nonconsolidated Carrying Amount Assets And Liabilities Net VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesNet	265300000	USD
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Estimates</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions.</span></div>
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36888000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41884000	USD
CY2020Q1	us-gaap	Restricted Cash RestrictedCash	15010000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	16936000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51898000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58820000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3400000	USD
CY2020Q1	nshi	Finance Lease Payments FinanceLeasePayments	200000	USD
CY2019Q1	nshi	Finance Lease Payments FinanceLeasePayments	200000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	620000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	646000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	554000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	133000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	40000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1993000	USD
CY2020Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	268000	USD
CY2020Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1725000	USD
CY2020Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.060
CY2020Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D
CY2020Q1	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	5987000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	6437000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	21387000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	21387000	USD
CY2020Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	380000	USD
CY2019Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	380000	USD
CY2020Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	27754000	USD
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	28204000	USD
CY2020Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	133000	USD
CY2019Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	151000	USD
CY2020Q1	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	27887000	USD
CY2019Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	28355000	USD
CY2020Q1	nshi	Amortizationof Deferred Costsand Intangible Assets AmortizationofDeferredCostsandIntangibleAssets	500000	USD
CY2019Q1	nshi	Amortizationof Deferred Costsand Intangible Assets AmortizationofDeferredCostsandIntangibleAssets	6800000	USD
CY2020Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense Remainderof Fiscal Year DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseRemainderofFiscalYear	1404000	USD
CY2020Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense Year Two DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1871000	USD
CY2020Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense Year Three DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseYearThree	594000	USD
CY2020Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense Year Four DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseYearFour	337000	USD
CY2020Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense Year Five DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseYearFive	337000	USD
CY2020Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense After Year Five DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1577000	USD
CY2020Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Net DeferredCostsandFiniteLivedIntangibleAssetsNet	6120000	USD
CY2020Q1	nshi	Acquisition Feeand Expense Cap AcquisitionFeeandExpenseCap	0.060
CY2020Q1	nshi	Healthcare Facility Regulatory Reserve HealthcareFacilityRegulatoryReserve	6000000	USD
CY2019Q4	nshi	Healthcare Facility Regulatory Reserve HealthcareFacilityRegulatoryReserve	6000000	USD
CY2020Q1	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	2327000	USD
CY2019Q4	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	2327000	USD
CY2020Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	6212000	USD
CY2019Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	3841000	USD
CY2020Q1	us-gaap	Lease Incentive Receivable LeaseIncentiveReceivable	1842000	USD
CY2019Q4	us-gaap	Lease Incentive Receivable LeaseIncentiveReceivable	1636000	USD
CY2020Q1	nshi	Utility Deposit Assets UtilityDepositAssets	315000	USD
CY2019Q4	nshi	Utility Deposit Assets UtilityDepositAssets	317000	USD
CY2020Q1	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	386000	USD
CY2019Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	368000	USD
CY2020Q1	us-gaap	Other Assets OtherAssets	17082000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	14489000	USD
CY2020Q1	nshi	Lease Terms Days Notice Required For Termination LeaseTermsDaysNoticeRequiredForTermination	30	D
CY2020Q1	nshi	Lease Terms Days Notice Required For Termination LeaseTermsDaysNoticeRequiredForTermination	30	D
CY2020Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	4200000	USD
CY2019Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	4000000.0	USD
CY2020Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2020Q1	nshi	Impairment Of Affiliate Properties ImpairmentOfAffiliateProperties	400000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	15700000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000	USD
CY2020Q1	us-gaap	Land Land	236036000	USD
CY2019Q4	us-gaap	Land Land	236036000	USD
CY2020Q1	us-gaap	Land Improvements LandImprovements	23379000	USD
CY2019Q4	us-gaap	Land Improvements LandImprovements	23287000	USD
CY2020Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1554484000	USD
CY2019Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1551113000	USD
CY2020Q1	us-gaap	Tenant Improvements TenantImprovements	15175000	USD
CY2019Q4	us-gaap	Tenant Improvements TenantImprovements	14642000	USD
CY2020Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2368000	USD
CY2019Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	4956000	USD
CY2020Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	102662000	USD
CY2019Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	100998000	USD
CY2020Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1934104000	USD
CY2019Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1931032000	USD
CY2020Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	246837000	USD
CY2019Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	230814000	USD
CY2020Q1	us-gaap	Real Estate Investments RealEstateInvestments	1687267000	USD
CY2019Q4	us-gaap	Real Estate Investments RealEstateInvestments	1700218000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	16000000.0	USD
CY2019Q1	us-gaap	Depreciation Depreciation	15600000	USD
CY2020Q1	us-gaap	Equity Method Investments EquityMethodInvestments	265309000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	268894000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-224000	USD
CY2019Q1	nshi	Equity Method Investment Select Revenuesand Expenses Net EquityMethodInvestmentSelectRevenuesandExpensesNet	-10084000	USD
CY2019Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	6947000	USD
CY2019Q1	nshi	Equity Method Investment Numberof Facilities Sold EquityMethodInvestmentNumberofFacilitiesSold	11	facility
CY2019Q1	nshi	Equity Method Investment Numberof Facilities Sold EquityMethodInvestmentNumberofFacilitiesSold	11	facility
CY2019Q1	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	118000000.0	USD
CY2019Q1	nshi	Proceeds From Sale Of Property Held For Sale Net ProceedsFromSaleOfPropertyHeldForSaleNet	4300000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-993000	USD
CY2020Q1	nshi	Equity Method Investment Select Revenuesand Expenses Net EquityMethodInvestmentSelectRevenuesandExpensesNet	-11808000	USD
CY2020Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1765000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	118000000.0	USD
CY2019Q1	nshi	Proceeds From Sale Of Property Held For Sale Net ProceedsFromSaleOfPropertyHeldForSaleNet	4300000	USD
CY2020Q1	nshi	Debt Instrument Numberof Instruments DebtInstrumentNumberofInstruments	1	Investment
CY2020Q1	nshi	Percentof Interest Income Contributedby Investment PercentofInterestIncomeContributedbyInvestment	1.000
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	17810000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	76169000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	466725000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	19056000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	19778000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	850154000	USD
CY2020Q1	us-gaap	Long Term Debt LongTermDebt	1449692000	USD
CY2019Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5780000	USD
CY2020Q1	nshi	Related Party Transaction Dueto Related Parties Amount Incurred RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred	7340000	USD
CY2020Q1	nshi	Related Party Transaction Dueto Related Parties Amount Paid RelatedPartyTransactionDuetoRelatedPartiesAmountPaid	8090000	USD
CY2020Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5030000	USD
CY2020Q1	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees	2500000	USD
CY2020Q1	nshi	Stock Redeemedor Called During Period Shares Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodSharesPaymentofAdvisorAssetManagementFees	400000	shares
CY2020Q1	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	2500000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38125	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45000	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	100000	USD
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	200000	USD
	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.00184932
	nshi	Common Stock Annualized Distribution CommonStockAnnualizedDistribution	0.675
CY2018	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.000924658
CY2018	nshi	Common Stock Annualized Distribution CommonStockAnnualizedDistribution	0.3375
CY2019Q1	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.000924658
CY2018Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	73500000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	300000	shares
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2000000.0	USD
CY2020Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	6.25
CY2019	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1500000	shares
CY2019	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10700000	USD
CY2019	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	7.10
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000	USD
CY2020Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	segment
CY2020Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	75	property
CY2020Q1	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	10515	unit
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	72891000	USD
CY2020Q1	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	72891000	USD
CY2020Q1	us-gaap	Interest Income Operating InterestIncomeOperating	1905000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45701000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	16679000	USD
CY2020Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	7000	USD
CY2020Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	4431000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3029000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16489000	USD
CY2020Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-993000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-12547000	USD
CY2019Q1	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	72521000	USD
CY2019Q1	us-gaap	Interest Income Operating InterestIncomeOperating	1902000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45218000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	17396000	USD
CY2019Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	38000	USD
CY2019Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	4994000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3054000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22399000	USD
CY2019Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	237000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-224000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-18669000	USD

Files In Submission

Name	View Source	Status
0001503707-20-000012-index-headers.html	Edgar Link	pending
0001503707-20-000012-index.html	Edgar Link	pending
0001503707-20-000012.txt	Edgar Link	pending
0001503707-20-000012-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nhi3312020proptype.jpg	Edgar Link	pending
nshi-20200331.xsd	Edgar Link	pending
nshi-20200331_cal.xml	Edgar Link	unprocessable
nshi-20200331_def.xml	Edgar Link	unprocessable
nshi-20200331_lab.xml	Edgar Link	unprocessable
nshi-20200331_pre.xml	Edgar Link	unprocessable
nshi0331202010-q.htm	Edgar Link	pending
nshi0331202010-q_htm.xml	Edgar Link	completed
nshi03312020exhibit311.htm	Edgar Link	pending
nshi03312020exhibit312.htm	Edgar Link	pending
nshi03312020exhibit321.htm	Edgar Link	pending
nshi03312020exhibit322.htm	Edgar Link	pending
nshi33120geogrlocation.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

2020 Q1 Form 10-Q Financial Statement

#000150370720000012 Filed on May 08, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS NorthStar Healthcare Income, Inc. Stock $nhhs

2020 Q1 Form 10-Q Financial Statement

#000150370720000012 Filed on May 08, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs